ZA929330B - Thiazolyl-substituted quinolylmethoxyphenylacetic acid derivatives. - Google Patents

Thiazolyl-substituted quinolylmethoxyphenylacetic acid derivatives.

Info

Publication number
ZA929330B
ZA929330B ZA929330A ZA929330A ZA929330B ZA 929330 B ZA929330 B ZA 929330B ZA 929330 A ZA929330 A ZA 929330A ZA 929330 A ZA929330 A ZA 929330A ZA 929330 B ZA929330 B ZA 929330B
Authority
ZA
South Africa
Prior art keywords
thiazolyl
acid derivatives
substituted
quinolylmethoxyphenylacetic acid
substituted quinolylmethoxyphenylacetic
Prior art date
Application number
ZA929330A
Other languages
English (en)
Inventor
Siegfried Raddatz
Klaus Helmut Mohrs
Michael Matzke
Romanis Fruchtmann
Armin Hatzelmann
Peddinghaus Reiner Mueller
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA929330B publication Critical patent/ZA929330B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
ZA929330A 1991-12-03 1992-12-02 Thiazolyl-substituted quinolylmethoxyphenylacetic acid derivatives. ZA929330B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4139751A DE4139751A1 (de) 1991-12-03 1991-12-03 Thiazolyl substituierte chinolylmethoxyphenylessigsaeurederivate
CA002061538A CA2061538A1 (en) 1991-02-22 1992-02-19 2-substituted quinolines, processes for their preparation and their use in medicaments

Publications (1)

Publication Number Publication Date
ZA929330B true ZA929330B (en) 1993-06-04

Family

ID=25674978

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA929330A ZA929330B (en) 1991-12-03 1992-12-02 Thiazolyl-substituted quinolylmethoxyphenylacetic acid derivatives.

Country Status (10)

Country Link
US (1) US5283252A (xx)
EP (1) EP0549879A3 (xx)
JP (1) JPH05247036A (xx)
AU (1) AU660742B2 (xx)
CA (2) CA2061538A1 (xx)
DE (1) DE4139751A1 (xx)
FI (1) FI925469A (xx)
HU (2) HU9203812D0 (xx)
NZ (1) NZ245328A (xx)
ZA (1) ZA929330B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4139750A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Chinolylmethoxyphenylessigsaeure-acylamide und -harnstoffe
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
US20060019269A1 (en) * 2002-10-17 2006-01-26 Decode Genetics, Inc. Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment
JP2006508180A (ja) * 2002-10-17 2006-03-09 デコード ジェネティクス イーエッチエフ． 心筋梗塞に対する感受性遺伝子；治療の方法
EP1660427A4 (en) 2003-08-14 2006-12-20 Asahi Kasei Pharma Corp SUBSTITUTED ARYLALKANIC DERIVATIVE AND ITS USE
CA2547518A1 (en) 2003-12-12 2005-06-30 Wyeth Quinolines useful in treating cardiovascular disease
US8158362B2 (en) 2005-03-30 2012-04-17 Decode Genetics Ehf. Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
CA2553928A1 (en) * 2004-01-30 2005-08-18 Decode Genetics Ehf. Susceptibility gene for myocardial infarction, stroke, and paod; methods of treatment
WO2008067566A1 (en) 2006-11-30 2008-06-05 Amira Pharmaceuticals, Inc. Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulators
EP3906925A1 (en) 2014-02-04 2021-11-10 Bioscience Pharma Partners, LLC Use of flap inhibitors to reduce neuroinflammation mediated injury in the central nervous system

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE520668A (xx) * 1956-06-28
US4725619A (en) * 1985-04-16 1988-02-16 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4728668A (en) * 1985-04-16 1988-03-01 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4631287A (en) * 1985-04-16 1986-12-23 Usv Pharmaceutical Corp. Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4868193A (en) * 1986-09-24 1989-09-19 Rorer Pharmaceutical Corporation Styryl tetrazoles and anti-allergic use thereof
KR870008853A (ko) * 1986-03-28 1987-10-21 오쯔까 아끼히꼬 하이드로퀴놀린 화합물의 제조방법
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
ZA894913B (en) * 1988-07-12 1990-03-28 Ici Pharma Heterocyclic compounds
US5089495A (en) * 1989-01-30 1992-02-18 Imperial Chemical Industries Plc Heterocyclic thiazole derivatives and pharmaceutical compositions comprising said derivatives
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
AU660742B2 (en) 1995-07-06
CA2061538A1 (en) 1993-08-20
FI925469A (fi) 1993-06-04
JPH05247036A (ja) 1993-09-24
CA2084131A1 (en) 1993-06-04
HUT65445A (en) 1994-06-28
US5283252A (en) 1994-02-01
HU9203812D0 (en) 1993-03-29
AU2979892A (en) 1993-06-10
DE4139751A1 (de) 1993-06-09
EP0549879A2 (de) 1993-07-07
NZ245328A (en) 1995-02-24
EP0549879A3 (de) 1993-07-14
FI925469A0 (fi) 1992-12-01

Similar Documents

Publication Publication Date Title
EP0520277A3 (en) 7-azaisoindolinyl-quinolone- and naphthyridoncarboxylic acid derivatives
EP0641203A4 (en) AMIDAZOLYL-ALCENOIC ACIDS.
ZA934603B (en) thiazolylvinylphenyl derivatives.
ZA919660B (en) Alpha-oxoacetamide derivatives.
PH30227A (en) 7-Isoindolinyl-quinolone-carboxylic acid derivatives
PH30977A (en) Hiv-inhibiting benzene-acetamide derivatives.
IL103538A0 (en) Quinoxaline-carboxylic and-phosphonic acid derivatives
ZA927955B (en) Cyclohexaneacetic acid derivatives.
ZA927500B (en) Substituted imidazolyl-propenoic acid derivatives.
DE59204008D1 (en) Trachealstent.
ZA927499B (en) Cyclic-substituted imidazolyl-propenoic acid derivatives.
ZA927501B (en) Imidazolyl-propenoic acid derivatives.
ZA929330B (en) Thiazolyl-substituted quinolylmethoxyphenylacetic acid derivatives.
OA09716A (en) Benzoxaiole derivatives.
EP0593464A4 (en) BENZOIC ACID DERIVATIVES.
HU9400745D0 (en) 2,4-diamino-3-hydroxy-carboxylic acid derivatives
DE69203865D1 (en) Thermo-transferdrucksystem.
HU9302728D0 (en) Pyridazinone-acetic acid derivatives
DE69204801D1 (en) Hydroxy- oder oxosubstituierte alkylcyclopentene.
ZA928275B (en) Quinoxaline-carboxylic and -phosphonic acid derivatives.
DE59200703D1 (en) Polyketomethinfarbstoffe.
ZA922831B (en) Novel thienyl-nonatetraenoic acid derivatives
ZA93737B (en) Aminobenzoic acid derivatives.
ZA924515B (en) 7-isoindolinyl-quinolone-and naphthyridonecarboxylic acid derivatives
ZA922022B (en) N-acyl-alpha-amino acid derivatives